A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., Nov. 9, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC),...
SARASOTA, Fla., Nov. 8, 2021 -- INVO Bioscience, Inc. ("INVO" or the "Company") (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), today announced it will regain full U.S. commercialization rights for its...
SARASOTA, Fla. and BALTIMORE, Oct. 20, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients...
Positib Fertility, an INVO Center, becomes first international JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and MONTERREY, Mexico, Oct. 14, 2021 -- INVO Bioscience, Inc. (NASDAQ:...
SARASOTA, Fla., Oct. 1, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, today announced that it has entered into definitive agreements with institutional...
Provides platform to leverage the existing INVOcell product registration in Canada and ongoing work with leading embryologist, Ric Ross, to establish INVO Centers and enhance distribution into existing fertility clinicsSARASOTA, Fla., Sept. 9, 2021 -- INVO Bioscience,...
Bloom Fertility, An INVO Center becomes the second JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and ATLANTA, Sept. 7, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device...
Dr. Carlsson will be speaking on the topic of INVOcell® as an efficient, patient-centric fertility solution for the growing demand in AfricaSARASOTA, Fla., Sept. 3, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing...
Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., Aug. 16, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., Aug. 5, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC),...